Gynecologic cancers in pregnancy: Guidelines of a second international consensus meeting

International Journal of Gynecological Cancer

Volumn 24, Issue 3, 2014, Pages 394-403

  Amant, Frédéric ^a   Halaska, Michael J ^b   Fumagalli, Monica ^c   Steffensen, Karina Dahl ^d   Lok, Christianne ^e   Van Calsteren, Kristel ^f   Han, Sileny N ^a   Mir, Olivier ^g   Fruscio, Robert ^h   Uzan, Cathérine ⁱ   Maxwell, Cynthia ^j   Dekrem, Jana ^a   Strauven, Goedele ^a   Gziri, Mina Mhallem ^a   Kesic, Vesna ^k   Berveiller, Paul ^l   Van Den Heuvel, Frank ^f   Ottevanger, Petronella B ^m   Vergote, Ignace ^a   Lishner, Michael ⁿ   Morice, Philippe ⁱ   Nulman, Irena ^o   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b CHARLES UNIVERSITY   (Czech Republic)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d LILLEBAELT HOSPITAL   (Denmark)

^e Gynecological Oncology Center for Gynecological Oncology Amsterdam   (Netherlands)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g Medical Oncology Cochin Teaching Hospital Paris Descartes University ^*  (France)

^h SAN GERARDO HOSPITAL   (Italy)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j MOUNT SINAI HOSPITAL   (Canada)

^k UNIVERSITY OF BELGRADE   (Serbia)

^l ARMAND TROUSSEAU HOSPITAL   (France)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ Medical Oncology Radboudziekenhuis ^*  (Israel)

^o HOSPITAL FOR SICK CHILDREN   (Canada)

more..

Author keywords

Cancer; Chemotherapy; Consensus; Gynecologic; Pregnancy

Indexed keywords

ANTIEMETIC AGENT; BEVACIZUMAB; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; GADOLINIUM; GEMCITABINE; MARKER; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PLATINUM; TOPOTECAN; TRAMADOL; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; BREAST FEEDING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; CONSENSUS; CONSULTATION; DELIVERY; DIAGNOSTIC PROCEDURE; DRUG SAFETY; ECHOGRAPHY; EVIDENCE BASED PRACTICE; GESTATIONAL AGE; GYNECOLOGIC CANCER; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HUMAN; INFORMATION; MATERNAL TREATMENT; MOTHER; NEONATOLOGIST; NEOPLASM; NEWBORN PERIOD; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTETRICIAN; OVARY CANCER; OVARY TUMOR; PATIENT MONITORING; PELVIS SURGERY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; REVIEW; SAFETY; SCAR FORMATION; SENTINEL LYMPH NODE BIOPSY; TERATOGENICITY; TERM BIRTH; TREATMENT PLANNING; TUMOR INVASION; UTERINE CERVIX CANCER; VULVA CANCER; CONSENSUS DEVELOPMENT; FEMALE; GENITAL NEOPLASMS, FEMALE; NEONATOLOGY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

ANTINEOPLASTIC AGENTS; DELIVERY, OBSTETRIC; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; NEONATOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 84899435414     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000062     Document Type: Review

References (30)

1. Han SN, Kesic VI, Van Calsteren K, et al. Cancer in pregnancy: a survey of current clinical practice. Eur J Obstet Gynecol Reprod Biol. 2013;167:18-23.
2. Amant F, Van Calsteren K, Halaska MJ, et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer. 2009;19(suppl 1):S1-S12.
3. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol. 2007;188:1447-1474.
4. Balleyguier C, Fournet C, Ben HW, et al. Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging. Clin Imaging. 2013; 37(1):70-76.
5. Telischak NA, Yeh BM, Joe BN, et al. MRI of adnexal masses in pregnancy. AJR Am J Roentgenol. 2008; 191:364-370.
6. Mazze RI, Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol. 1989;161:1178-1185.
7. Bunyavejchevin S, Phupong V. Laparoscopic surgery for presumed benign ovarian tumor during pregnancy. Cochrane Database Syst Rev. 2013;1:CD005459.
8. Evans SR, Sarani B, Bhanot P, et al. Surgery in pregnancy. Curr Probl Surg. 2012;49:333-388.
9. Anderka M, Mitchell AA, Louik C, et al. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94:22-30.
10. Pasternak B, Svanstrom H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368:814-823.
11. Koren G, Florescu A, Costei AM, et al. Nonsteroidal anti-inflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40:824-829.
12. Van Calsteren K, Verbesselt R, Ottevanger N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand. 2010;89:1338-1345.
13. Amant F, von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31:2532-2539.
14. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283-291.
15. Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010; 33:221-228.
16. Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28:683-689.
17. Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;13:256-264.
18. Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219-1226.
19. Sood AK, Sorosky JI, Mayr N, et al. Radiotherapeutic management of cervical carcinoma that complicates pregnancy. Cancer. 1997;80:1073-1078.
20. Rob L, Skapa P, Robova H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 2011; 12:192-200.
21. Schmeler KM, Frumovitz M, Ramirez PT. Conservative management of early stage cervical cancer: is there a role for less radical surgery? Gynecol Oncol. 2011; 120:321-325.
22. Morice P, Uzan C, Gouy S, et al. Gynaecological cancers in pregnancy. Lancet. 2012;379:558-569.
23. Rydzewska L, Tierney J, Vale CL, et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 2012;12:CD007406.
24. Zagouri F, Sergentanis TN, Chrysikos D, et al. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013;121:337-343.
25. Cardonick E, Bhat A, Gilmandyar D, et al. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol. 2012;23:3016-3023.
26. Zhao XY, Huang HF, Lian LJ, et al. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer. 2006;16:8-15.
27. Zagouri F, Sergentanis TN, Chrysikos D, et al. Taxanes for ovarian cancer during pregnancy: a systematic review. Oncology. 2012;83:234-238.
28. Motegi M, Takakura S, Takano H, et al. Adjuvant chemotherapy in a pregnant woman with endodermal sinus tumor of the ovary. Obstet Gynecol. 2007;109:537-540.
29. Morice P, Narducci F, Mathevet P, et al. French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer. 2009;19:1638-1641.
30. Alexander A, Harris RM, Grossman D, et al. Vulvar melanoma: diffuse melanosis and metastasis to the placenta. J Am Acad Dermatol. 2004; 50:293-298.